(Q44094549)

English

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kanda Y

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Izutsu K

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hirai H

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sakamaki H

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Iseki T

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kodera Y

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Okamoto S

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Mitsui H

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Iwato K

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hirabayashi N

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Furukawa T

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Maruta A

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kasai M

13

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Atsuta Y

14

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hamajima N

15

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hiraoka A

16

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kawa K

17

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1013-1019

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403343

0 references

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Acute graft-vs-host disease: pathobiology and management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

21 January 2018

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403343

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403343

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44094549&oldid=2106536829"